AstraZeneca follows rival Boehringer in capping out-of-pocket costs for inhalers
(Reuters) – Drugmaker AstraZeneca said on Monday it would cap out-of-pocket costs for its inhaled respiratory products at $35 p..
News
All Posts

(Reuters) – Drugmaker AstraZeneca said on Monday it would cap out-of-pocket costs for its inhaled respiratory products at $35 p..
News

New Banksy mural depicting tree foliage appears in north London LONDON (Reuters) – A new artwork by British street artist Banksy..
Headlines

Dollar dips, yen steady as BOJ policy shift beckons By Herbert Lash and Harry Robertson NEW YORK/LONDON (Reuters) -The dollar was litt..
Finance

In an era where technology intertwines with daily life more seamlessly than ever, the financial sector has not remained untouched. Th..
Finance

..
Headlines

..
Headlines

..
Headlines

..
Technology

..
Headlines

..
Headlines

..
Headlines

..
Headlines

..
Headlines

..
Headlines

..
Headlines

Safety and security concerns Despite the promise of increased safety, the transition to autonomous vehicles raises significant safety..
Technology

..
Headlines

..
Headlines

..
Headlines

..
Headlines

..
Headlines

..
Headlines

..
Finance

..
Headlines

Trade finance represents the fuel powering the engine of international commerce, facilitating transactions across borders with ease a..
Business

..
Headlines

..
Headlines

..
Headlines

..
Headlines

..
Headlines

..
Finance

..
Headlines

..
Headlines

..
Headlines

..
Headlines

..
Featured

..
Headlines